Document is current
Any future updates will be listed below
-
Authors
Thijs, Roland D. https://orcid.org/0000-0003-1435-8970
Brignole, Michele https://orcid.org/0000-0002-1845-5607
Falup-Pecurariu, Cristian https://orcid.org/0000-0002-7394-7161
Fanciulli, Alessandra https://orcid.org/0000-0002-2854-4179
Freeman, Roy https://orcid.org/0000-0003-3976-6022
Guaraldi, Pietro https://orcid.org/0000-0003-0597-603X
Jordan, Jens https://orcid.org/0000-0003-4518-0706
Habek, Mario https://orcid.org/0000-0002-3360-1748
Hilz, Max https://orcid.org/0000-0002-6802-1751
Traon, Anne Pavy-Le https://orcid.org/0000-0002-9375-1553
Stankovic, Iva
Struhal, Walter https://orcid.org/0000-0001-7360-7784
Sutton, Richard
Wenning, Gregor
Van Dijk, J. Gert https://orcid.org/0000-0002-6953-7573
-
Funding
Funding for this research was provided by:
Leiden University Medical Center
- License Information
-
More Information
Article History
Received: 4 July 2020
Accepted: 12 October 2020
First Online: 19 March 2021
Compliance with ethical standards
:
: Dr. Thijs reports personal fees from Medtronic, Union Chimique Belge (UCB), GlaxoSmithKline (GSK), Theravance, Novartis and grants from Dutch National Epilepsy Fund, Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie, AC Thomson Foundation, Medtronic, The Netherlands Organisation for Health Research and Development (843002707), outside the submitted work. Dr Fanciulli reports royalties from Springer Nature Publishing Group and Thieme Verlag, speaker fees from the Austrian Autonomic Society, Austrian Neurology Society, Austrian Parkinson Society, Ordensklinikum Linz, International Parkinson Disease and Movement Disorders Society and Theravance Biopharma, research grants from the Stichting ParkinsonFond, MSA Coalition and the Österreichischer Austausch Dienst, outside the submitted work. Prof Sutton serves as consultant to Medtronic Inc., is a member of the Speakers Bureau of SJM Abbott Laboratories, and shareholder in Edwards Lifesciences and Boston Scientific Corp., outside of the submitted work. Prof Pavy-Le Traon reports a research grant from the French Ministry of Health outside the submitted work. Prof Jordan served as advisor for Novo-Nordisk, Bayer, received research support from Boston Scientific and Boehringer Ingelheim and is cofounder of Eternygen GmbH, outside the submitted work. Prof. Habek participated as clinical investigator, speaker and/or advisor for Biogen, Sanofi Genzyme, Merck, Bayer, Novartis, Pliva/Teva, Roche, Alvogen, Actelion, Alexion Pharmaceuticals, outside the submitted work. Prof Struhal reports consultancy for Boehringer, Eli Lilly, royalties from Manz-Rechtsverlag, Springer, Oxford University Press, speaker fees from Boehringer, Merz, Medconvent, Donau-Universität Krems, Austrian Society of Neurology, Manz-Rechtsverlag. Prof. Hilz received consulting honoraria from Alnylam and Sanofi-Genzyme, lecturing honoraria and travel support from Bayer HealthCare, Amicus, Sanofi-Genzyme, and research funding from Novartis Pharma and Bayer Health Care.
